Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05842044 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NSAID Use After Robotic Partial Nephrectomy

Study acronym: No-PAIN
StatusRecruiting
PhasePhase 2
Started2023-09-15
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 24, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-25
minor
Completion pushed: 2026-09-30 → 2026-12-31
2025-09-03
minor
Study Status v6
Primary completion date2025-09-30→2026-09-30
Completion date2025-09-30→2026-09-30
2024-10-04
minor
Study Status v5
Re-verified, no change to tracked fields
2023-11-03
minor
Study Status, Outcome Measures v4
Primary completion date2025-09-05→2025-09-30
Completion date2025-09-05→2025-09-30
Start date2023-09-05→2023-09-15
Secondary endpointsdetails revised at 4 of 5 entries
2023-09-05
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v3
Trial statusNot Yet Recruiting→Recruiting
Study sitesdetails revised at 1 of 1 site
Show 2 earlier versions
2023-08-23
minor
Study Status v2
Primary completion date2025-08-31→2025-09-05
Completion date2025-08-31→2025-09-05
Start date2023-08-31→2023-09-05
2023-07-25
minor
Study Status v1
Primary completion date2025-07-31→2025-08-31
Completion date2025-07-31→2025-08-31
Start date2023-07-31→2023-08-31
2023-04-24
minor
Original filing
The purpose of this study is to see how effective non-steroidal anti-inflammatory drugs (NSAIDs) are at controlling pain without side effects in participants after robotic-assisted partial nephrectomy.
Trial Details
NCT Number NCT05842044
Lead Sponsor University of Miami
Conditions Kidney Cancer, Renal Cancer, Renal Neoplasm
Enrollment 110 participants
Start Date 2023-09-15
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-09-24